General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: http://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. Download date: 09 May 2018Provided for non-commercial research and educational use only.Not for reproduction or distribution or commercial use.This article was originally published by IWA Publishing. IWA Publishing recognizes the retention of the right by the author(s) to photocopy or make single electronic copies of the paper for their own personal use, including for their own classroom use, or the personal use of colleagues, provided the copies are not offered for sale and are not distributed in a systematic way outside of their employing institution.Please note that you are not permitted to post the IWA Publishing PDF version of your paper on your own website or your institution's website or repository.Please direct any queries regarding use or permissions to wst@iwap.co.ukDevelopment of a common priority list of pharmaceuticals relevant for the water cycle Pharmaceutically active compounds (PhACs), including prescription drugs, over-the-counter medications, drugs used in hospitals and veterinary drugs, have been found throughout the water cycle. A desk study was initiated by the Global Water Research Coalition to consolidate a uniform selection of such compounds in order to judge risks of PhACs for the water cycle. By identifying major existing prioritization efforts and evaluating the criteria they use, this study yields a representative and qualitative profile ('umbrella view') of priority pharmaceuticals based on an extensive set of criteria. This can then be used for further studies on analytical methods, occurrence, treatability and potential risks associated with exposure to PhACs in water supply, identifying compounds most likely to be encountered and that may have significant impact on human health. For practical reasons, the present study excludes veterinary drugs. The pragmatic approach adopted provides an efficient tool to manage risks related to pharmaceuticals and provides assistance for selecting compounds for future studies.

No abstract

This paper illustrates the challenge faced by analytical chemists when trying to measure selected compounds representative of various classes of prescription and hospital drugs. Because hundreds of drugs belonging to a wide variety of chemical groups are allowed for use, an array of analytical methods has to be implemented. As an example, as part of the European Poseidon Project, five different methods were required to measure eight drugs and personal care products. These methods are discussed in detail. Examples of application to surface and ground waters from the Paris area are also reported. The antibiotics roxithromycin and sulfamethoxazole were detected for the first time in the Seine River downstream of Paris. The behaviour of the eight target compounds during aquifer recharge and drinking water treatment is described. An incident involving the detection of micrograms per litre levels of the personal care product Galaxolide in a drinking water distribution system is reported. The value of the pharmaceuticals and personal care products selected as potential indicators is also discussed.

The objective of the study was to identify appropriate analytical scenarios to assess the release of emerging toxins in water resources and manage the risk for drinking water. A comprehensive toolbox was developed for the monitoring of cyanobacteria and cyanotoxins in ten water resources used for drinking water production and known for regular algae blooms. Six toxins - microcystins, cylindrospermopsin, anatoxins, nodularin, saxitoxin and BMAA - were targeted. High performance HPLC-MS/MS methods were implemented in parallel with rapid kits and a real-time PCR method was developed to identify specifically the microcystin producing species. Those analytical methods were found in good agreement and very sensitive and selective. Low levels of eutrophication were obtained during those campaigns leading to limited occurrence of toxins. Results obtained on one site are detailed in this paper. Finally, recommendations could be drawn to manage the risk related to various emerging algae toxins, based on the use of a phycocyanin probe on-site as early-warning system. When a threshold value is reached, treatment and monitoring strategies are implemented in parallel.

More than 110 volatile and base-neutral compounds or groups of compounds with concentrations exceeding 0.1 µg/L were identified in a wastewater treatment plant, at different stages of treatment. Individual concentrations ranged from 0.1 µg/L to 1 mg/L. The concentrations of many micropollutants were increased after mixing the raw water with recycled waters from the sludge drying process. Six compounds listed among the 33 priority pollutants from the Water Framework Directive, were detected. Due to the high efficiency of the treatment process and to the high dilution ratio at the outlet, this plant showed little influence on the receiving water.